Three Sweeteners for Blood Sugar

Overseen ByJohn B Jarman, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: LOAM Science

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is using a double-blind, randomize crossover evaluating the impact of three different sweeteners on postprandial glycemic response in a mixed meal setting. In 50 individuals, postprandial glucose response will be evaluated as a primary objective. Secondary objectives include additional measures of glucose response as well general gastrointestinal response to the sweeteners, assessed through a series of questionnaires.

Are You a Good Fit for This Trial?

This trial is for adults in the US, ages 18 and up, with a BMI between 18.5 and 29.9 who are generally healthy (no diabetes or prediabetes). Participants must be able to eat a standard breakfast, wear a glucose monitor for about 10 days, follow fasting instructions, use a smartphone app, and consent electronically.

Inclusion Criteria

I live in the United States and can receive packages at my home address.

I can read, understand, and speak English.

I am willing and able to give consent electronically.

See 7 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares how three sweeteners—sugar, stevia, and a LOAM fiber-based sweetener—affect blood sugar after eating. Each participant tries all three in random order during six test mornings using double-blind methods.